Clovis Oncology Inc (NASDAQ:CLVS)

82.09
Delayed Data
As of May 01
 +1.73 / +2.15%
Today’s Change
35.33
Today|||52-Week Range
94.88
+46.59%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.0013.6M
 
 
Depreciation And Amortization185.0K353.0K250.0K3.9M
 
 
 
 
 
 
Operating ExpensesGross Income-185.0K---250.0K9.8M
 
 
 
 
General Expenses47.4M69.2M80.7M158.7M
 
 
 
 
 
Research And Development40.7M58.9M66.5M137.7M
 
 
 
 
 
Total Operating Expenses47.6M69.5M80.9M162.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-47.6M-69.5M-80.9M-148.9M
 
 
 
 
 
Extraordinary Charge-7.0M-4.3M-2.9M-9.5M
 
 
 
 
 
Interest Expense On Debt0.000.00--2.6M
 
 
Other Expenses-957.0K-228.0K-713.0K3.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-55.5M-74.0M-84.5M-157.7M
 
 
 
 
 
Income Taxes-27.0K-27.0K-52.0K-2.3M
 
 
 
 
 
Net Income-55.6M-74.0M-84.5M-160.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS26.1M24.9M28.7M33.9M
 
 
 
 
 
Shares To Calculate EPS Diluted26.1M24.9M28.7M33.9M
 
 
 
 
 
 
Earnings Per ShareEPS-$14.42-$2.97-$2.95-$4.72
 
 
 
 
 
EPS Diluted-$2.13-$2.97-$2.95-$4.72
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account